EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CELU: Celularity Inc

22 Oct 25 15:30
LAST:

2.010

CHANGE:
 0.00		OPEN:
2.070		HIGH:
2.070		ASK:
0.000		VOLUME:
37.6K
CHG(%):
0.00		PREV:
2.010		LOW:
1.940		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Oct 252.0702.0701.9402.01037.6K
21 Oct 252.0202.0401.9502.02026.8K
20 Oct 251.9902.0301.9602.00036.5K
17 Oct 252.1402.1401.9311.980144.1K
16 Oct 252.0902.2102.0702.13066.6K
15 Oct 252.2602.2702.1502.17064.5K
14 Oct 252.0102.3502.0102.2701.71M
13 Oct 252.1002.1001.9912.04092.9K
10 Oct 252.1302.1651.9952.05076.3K
09 Oct 252.1502.2202.0802.13058.5K

COMPANY PROFILE

Name:Celularity Inc
About:Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:170 Park Avenue, Florham Park, NJ, United States, 07932
Website:https://www.celularity.com
CUSIP:151190105
CIK:0001752828
ISIN:US1511901050
FIGI:BBG00P2RTT34

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:2.030.8%
MA10:2.083.4%
MA20:2.093.9%
MA50:2.5828.3%
MA100:2.5024.6%
MA200:2.177.9%
STO9:4.76 
STO14:4.76 
RSI14:47.84
WPR14:-93.93 
MTM14:-0.13
ROC14:-0.06 
ATR:0.15 
Week High:2.2712.9%
Week Low:1.934.1%
Month High:2.3516.9%
Month Low:1.937.9%
Year High:5.22159.7%
Year Low:1.00101.0%
Volatility:17.63 

RECENT SPLITS

Date Ratio
29 Feb 20241-10